Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

Neuroepidemiology
I L NotkolaA Nissinen

Abstract

The epsilon 4 allele of the apolipoprotein E (apoE) is associated with Alzheimer's disease (AD) and also with elevated serum total cholesterol and low-density lipoprotein levels. However, the interrelationships between apoE genotype, plasma cholesterol levels and AD risk have been studied very little. We examined the possible role of serum total cholesterol in the pathogenesis of AD in a population-based sample of 444 men, aged 70-89 years, who were survivors of the Finnish cohorts of the Seven Countries Study. Previous high serum cholesterol level (mean level > or = 6.5 mmol/l) was a significant predictor of the prevalence of AD (odds ratio = 3.1; 95% confidence interval = 1.2, 8.5) after controlling for age and the presence of apoE epsilon 4 allele. In men who subsequently developed AD the cholesterol level decreased before the clinical manifestations of AD. We conclude that high serum total cholesterol may be an independent risk factor for AD and some of the effect of the apoE epsilon 4 allele on risk of AD might be mediated through high serum cholesterol.

Citations

Nov 16, 2011·Archives of Neurology·Nina E ShepardsonDennis J Selkoe
Oct 23, 2002·Journal of Neuroscience Research·Katsuhiko Yanagisawa
May 17, 2006·Aging Clinical and Experimental Research·Francesco PanzaAntonio Capurso
Mar 29, 2006·Cellular and Molecular Life Sciences : CMLS·K Pahan
May 25, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Rupinder K SodhiAmteshwar S Jaggi
Nov 19, 2013·European Archives of Psychiatry and Clinical Neuroscience·P ToroP Schönknecht
Jun 9, 2007·Journal of Neural Transmission·M WeihJ Kornhuber
Feb 24, 2011·Journal of Neural Transmission·Imrich BlaskoPeter Fischer
Aug 3, 2005·Cellular and Molecular Neurobiology·Walter J LukiwNicolas G Bazan
Sep 29, 2009·Journal of Bioenergetics and Biomembranes·Anna ColellJosé C Fernández-Checa
Jan 19, 2013·Current Atherosclerosis Reports·Christiane Reitz
Sep 6, 2002·Journal of Molecular Neuroscience : MN·Suzana S PetanceskaLorenzo M Refolo
Jul 12, 2008·Journal of Molecular Neuroscience : MN·Henri J HuttunenDora M Kovacs
Aug 26, 2009·Journal of Molecular Neuroscience : MN·Anália Nusya Medeiros GarciaLuiz Athayde-Junior
Oct 29, 2010·Journal of Molecular Neuroscience : MN·Alessio CrestiniAnnamaria Confaloni
Feb 11, 2014·Cell Metabolism·Sophie StukasCheryl L Wellington
Aug 28, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Swetha VijayaraghavanTaher Darreh-Shori
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gary LandrethMichael Heneka
Mar 8, 2005·Survey of Ophthalmology·Robyn Heather GuymerPaul Nigel Baird
Jul 7, 2001·Journal of the Neurological Sciences·B Cucchiara, S E Kasner
Nov 23, 2000·Lancet·H JickD A Drachman
Jul 18, 2002·Trends in Pharmacological Sciences·Diana Ines Dominguez, Bart De Strooper
Jan 13, 2001·Archives of Gerontology and Geriatrics·A AlgotssonB Winblad
Apr 13, 2000·Neurochemistry International·H KölschM L Rao
Jun 27, 2000·Neurobiology of Aging·R N Kalaria
Apr 26, 2003·Neurobiology of Aging·Richard A FrankUNKNOWN National Institute on Aging Biological Markers Working Group
Jul 11, 2002·Free Radical Biology & Medicine·Miguel A PappollaLorenzo M Refolo
Dec 12, 2002·Micron : the International Research and Review Journal for Microscopy·J R Harris
Oct 9, 2001·Drug Discovery Today·T E. Golde, C B. Eckman
Nov 10, 2011·The Proceedings of the Nutrition Society·Martha C Morris
Jul 16, 2011·Development and Psychopathology·Robert-Paul JusterSonia J Lupien
Jul 17, 2012·Chemical Reviews·Kasper P Kepp
Apr 1, 2011·Molecular BioSystems·Christopher M ValdezFidel Santamaria
Jan 5, 2000·The Australian and New Zealand Journal of Psychiatry·R StewartA Mann
Apr 13, 2001·Journal of the American Geriatrics Society·R StewartA Mann
Nov 2, 2002·Journal of the American Geriatrics Society·Eric G RodriguezMary Ganguli

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.